Professor
LVTS, UMR_S1148 INSERM, Paris, France
Philippe, Pharm D, PhD, has been a full Professor of Biochemistry at the University Paris-Saclay (school of Pharmacy) with protein/antibody engineering skills that focus on humanization since 2008. He uses molecular engineering methods and modelling based approach to design, engineer, affinity mature and humanize antibodies. Philippe co-founded Acticor-Biotech, a clinical stage Biotech dedicated to the development of an innovative treatment of stroke (www.acticor-biotech.com). The lead, Glenzocimab (ACT017), is now undergoing clinical trials phase IIb/IIIa.
Sunday, July 10, 2022
6:30 PM – 7:30 PM